No valuation for QL Biopharm is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($142.7M) and the funding record below are the closest available signals.
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for QL Biopharm
- ·The full record, as it builds
Funding history
No funding rounds for QL Biopharm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
How QL Biopharm's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For QL Biopharm, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has QL Biopharm raised?
- QL Biopharm has raised $142.7M in total funding across its recorded rounds.